These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28744887)

  • 21. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials.
    Tao Z; Toms BB; Goodisman J; Asefa T
    Chem Res Toxicol; 2009 Nov; 22(11):1869-80. PubMed ID: 19817448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organically Modified Silica Nanoparticles Interaction with Macrophage Cells: Assessment of Cell Viability on the Basis of Physicochemical Properties.
    Kumar D; Mutreja I; Keshvan PC; Bhat M; Dinda AK; Mitra S
    J Pharm Sci; 2015 Nov; 104(11):3943-3951. PubMed ID: 26295279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material.
    Fruijtier-Pölloth C
    Toxicology; 2012 Apr; 294(2-3):61-79. PubMed ID: 22349641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silica nanoparticles as sources of silicic acid favoring wound healing in vitro.
    Quignard S; Coradin T; Powell JJ; Jugdaohsingh R
    Colloids Surf B Biointerfaces; 2017 Jul; 155():530-537. PubMed ID: 28494431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
    An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs.
    Morris AS; Adamcakova-Dodd A; Lehman SE; Wongrakpanich A; Thorne PS; Larsen SC; Salem AK
    Toxicol Lett; 2016 Jan; 241():207-15. PubMed ID: 26562768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term fate of silica nanoparticles interacting with human dermal fibroblasts.
    Quignard S; Mosser G; Boissière M; Coradin T
    Biomaterials; 2012 Jun; 33(17):4431-42. PubMed ID: 22425552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescent non-porous silica nanoparticles for long-term cell monitoring: cytotoxicity and particle functionality.
    Soenen SJ; Manshian B; Doak SH; De Smedt SC; Braeckmans K
    Acta Biomater; 2013 Nov; 9(11):9183-93. PubMed ID: 23664886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size-dependent cellular uptake efficiency, mechanism, and cytotoxicity of silica nanoparticles toward HeLa cells.
    Zhu J; Liao L; Zhu L; Zhang P; Guo K; Kong J; Ji C; Liu B
    Talanta; 2013 Mar; 107():408-15. PubMed ID: 23598242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic effects in 3T3-L1 mouse and WI-38 human fibroblasts following 72 hour and 7 day exposures to commercial silica nanoparticles.
    Stępnik M; Arkusz J; Smok-Pieniążek A; Bratek-Skicki A; Salvati A; Lynch I; Dawson KA; Gromadzińska J; De Jong WH; Rydzyński K
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):89-101. PubMed ID: 22705593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reliable approach for assessing size-dependent effects of silica nanoparticles on cellular internalization behavior and cytotoxic mechanisms.
    Kim W; Kim WK; Lee K; Son MJ; Kwak M; Chang WS; Min JK; Song NW; Lee J; Bae KH
    Int J Nanomedicine; 2019; 14():7375-7387. PubMed ID: 31686813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
    Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
    J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-Triggered Gatekeeper-Enveloped Starlike Hollow Silica Nanoparticles for Intelligent Delivery Systems.
    Zhao N; Lin X; Zhang Q; Ji Z; Xu FJ
    Small; 2015 Dec; 11(48):6467-79. PubMed ID: 26528765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Size-dependent Cytotoxicity of Amorphous Silica Nanoparticles: A Systematic Review of in vitro Studies.
    Dong X; Wu Z; Li X; Xiao L; Yang M; Li Y; Duan J; Sun Z
    Int J Nanomedicine; 2020; 15():9089-9113. PubMed ID: 33244229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
    Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
    ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
    Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoengineered silica: Properties, applications and toxicity.
    Mebert AM; Baglole CJ; Desimone MF; Maysinger D
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):753-770. PubMed ID: 28578101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dispersion Behaviour of Silica Nanoparticles in Biological Media and Its Influence on Cellular Uptake.
    Halamoda-Kenzaoui B; Ceridono M; Colpo P; Valsesia A; Urbán P; Ojea-Jiménez I; Gioria S; Gilliland D; Rossi F; Kinsner-Ovaskainen A
    PLoS One; 2015; 10(10):e0141593. PubMed ID: 26517371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.